Article Details
Retrieved on: 2022-09-16 06:53:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Moderna (NASDAQ:MRNA – Get Rating) had its price target reduced by Argus from $180.00 to $150.00 in a note issued to investors on Wednesday, ...
Article found on: reporter.am
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here